Bafna Pharmaceuticals has informed that it enclosing Certificate dated 4th April 2022 issued by Cameo Corporate Services, Registrar and Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
The above information is a part of company’s filings submitted to BSE.